Dermatology · Basal Cell Carcinoma

Monitoring and Long-Term Skin Health

At a Glance

After basal cell carcinoma, regular dermatologist visits and monthly self-exams help find new or recurring skin cancers early. Use shade, protective clothing, and broad-spectrum SPF 30 sunscreen, and seek prompt care for persistent or worsening symptoms.

Life after a Basal Cell Carcinoma (BCC) diagnosis involves a shift in perspective. While the prognosis for your current tumor is excellent, having one BCC means your skin has sustained damage that puts you at a higher risk for developing new primary skin cancers in the future ^[1]. Long-term management is about balance: staying vigilant for new developments without letting “skin-check anxiety” take over your daily life.

When to Contact Your Care Team

Most changes related to BCC are slow-moving. However, you should report any new or changing lesion to your dermatologist, rather than waiting for it to look like a “typical” bump. Schedule an evaluation if you notice:

A New Bump or Spot: A pearly, skin-colored, or pink bump, or a patch that looks different from your other moles ^[2].
A “Non-Healing” Spot: A patch of skin that crusts over, bleeds easily, or seems to heal and then returns ^[3].
A Suspected Recurrence: A new growth appearing directly on or near your surgical scar ^[4].

Urgent vs. Emergency Symptoms

While extremely rare, BCC can sometimes grow along nerves (perineural invasion) or into the area around the eye (orbital invasion) ^[5]^[6].

EMERGENCY: Sudden facial weakness, sudden drooping, or sudden vision loss/double vision can be signs of unrelated, life-threatening medical emergencies (like a stroke). Seek emergency medical care immediately for sudden, severe symptoms.

URGENT: Persistent or progressive symptoms in the area of your previous BCC require urgent specialist assessment to rule out deep invasion ^[7]:

Persistent Facial Numbness: Ongoing tingling, “pins and needles,” or loss of feeling ^[8].
Progressive Weakness/Vision Changes: Slowly worsening difficulty moving part of your face or ongoing double vision ^[9]^[5].
Deep Bone Pain: Persistent, deep-seated pain in the previously treated area ^[8].

Your Surveillance Schedule

Regular skin checks are the cornerstone of your long-term health. Follow-up is highly individualized, but routine full-body professional skin examinations—commonly at least annually—are generally recommended ^[10]:

Routine Follow-Up: Your dermatologist will set a schedule. Many patients are seen every 6 to 12 months.
High-Risk Follow-Up: If you have had multiple tumors, aggressive subtypes, or a suppressed immune system, you may be scheduled for professional checks every 3 to 6 months ^[10]^[11].
Future Risk: Study estimates indicate that a significant portion of patients (roughly 40% in some cohorts) will develop another BCC within five years, highlighting why routine checks are vital ^[1]. (Note: Routine imaging scans or blood tests are generally not part of BCC follow-up unless specific symptoms arise).

Sun Protection Strategies

Modern sun protection is about a “layered” approach rather than relying on a single product ^[12].

Seek Shade: Avoid direct exposure during peak UV hours, typically between 10:00 AM and 4:00 PM ^[13].
Wear Protection: Tightly woven UPF clothing, broad-brimmed hats, and UV-rated sunglasses provide reliable physical protection ^[14].
Apply and Reapply Sunscreen: Use a broad-spectrum sunscreen with at least SPF 30 every day. Reapply every two hours if you are active or swimming ^[15].
Avoid Artificial UV: Never use tanning beds, as they significantly increase the risk of developing further skin cancers ^[16].

Self-Exams: Once a month, use a full-length mirror and a hand mirror (or ask a partner) to check your skin, including hard-to-see areas like the scalp. Take photographs of your surgical scars so you have a baseline to compare against.

Common questions in this guide

How often should I see a dermatologist after basal cell carcinoma?

Your dermatologist will individualize follow-up, but many people have a full-body skin examination every 6 to 12 months. At least yearly checks are common, while people with multiple tumors, aggressive tumor types, or a weakened immune system may need visits every 3 to 6 months.

What changes should I report after treatment for basal cell carcinoma?

Contact your dermatologist about any new or changing bump or patch, especially a pearly, pink, or skin-colored growth. Also report a spot that repeatedly crusts, bleeds, or fails to heal, or a new growth on or near the treatment scar.

Which symptoms after BCC need urgent or emergency care?

Persistent or gradually worsening numbness, facial weakness, double vision, or deep pain near the previously treated area needs urgent specialist assessment. Sudden facial weakness, facial drooping, sudden vision loss, or sudden double vision can signal a medical emergency, so seek emergency medical care immediately.

How can I lower my risk of more skin cancer after BCC?

Use several forms of sun protection: seek shade during peak UV hours, wear tightly woven protective clothing, a broad-brimmed hat, and UV-rated sunglasses, and apply broad-spectrum SPF 30 or higher sunscreen daily. Reapply sunscreen every two hours when active or swimming, and avoid tanning beds.

How should I check my skin at home after basal cell carcinoma?

Once a month, examine your whole skin with a full-length mirror and a hand mirror, or ask a partner to help with hard-to-see areas such as the scalp and back. Photograph surgical scars so you can notice changes from your usual appearance.

How likely is another basal cell carcinoma after I have had one?

Having one basal cell carcinoma increases your risk of developing another skin cancer. In some study groups, roughly 40% of patients developed another basal cell carcinoma within five years, but your personal risk depends on factors such as previous tumor history, immune status, and sun exposure.

Do I need routine scans or blood tests after basal cell carcinoma?

Routine imaging scans and blood tests are generally not part of follow-up for basal cell carcinoma when there are no concerning symptoms. Your clinician may order additional testing if symptoms or examination findings suggest deeper or recurrent disease.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on skin basal cell carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Based on my history of BCC, how often do you recommend I come in for a professional full-body skin examination?
2.Since I had a BCC in a high-risk location, what specific symptoms should I be watching for that warrant an urgent call to the clinic?
3.Can you show me or a family member how to perform a thorough skin self-exam and what specifically to look for on my surgical scar?
4.Are there specific sunscreen ingredients or clothing brands you recommend for my skin type and activity level?
5.If I notice a new suspicious spot, how quickly can I typically get in for an evaluation?

Key takeaways

Having one basal cell carcinoma increases the risk of developing another skin cancer, so long-term monitoring remains important even when the current tumor has an excellent prognosis.
Many patients need professional full-body skin examinations every 6 to 12 months, while people at higher risk may need checks every 3 to 6 months.
New or changing lesions, spots that crust or bleed and do not heal, and growth on or near a treatment scar should be evaluated by a dermatologist.
Monthly self-exams and layered UV protection, including shade, protective clothing, and broad-spectrum SPF 30 or higher sunscreen, help protect long-term skin health.
Persistent or progressive facial numbness, weakness, vision changes, or deep pain near the treated area needs urgent assessment, while sudden severe symptoms require emergency care.

References (16)

1
Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR, Linos E, Parvataneni R, et al.
JAMA dermatology 2015; (151(4)):382-8 doi:10.1001/jamadermatol.2014.3307.
PMID: 25588079
2
Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.
Lupu M, Caruntu C, Ghita MA, et al.
Disease markers 2016; (2016()):9831237 doi:10.1155/2016/9831237.
PMID: 27578920
3
Superficial Basal Cell Carcinoma on the Back Region Treated with a Combination of Cryotherapy and 5% Imiquimod Cream: A Case Report.
Sutedja EK, Elgianda GS, Sutedja E, Ruchiatan K
International medical case reports journal 2023; (16()):391-396 doi:10.2147/IMCRJ.S409840.
PMID: 37398930
4
Guidelines of care for the management of basal cell carcinoma.
, , Kim JYS, et al.
Journal of the American Academy of Dermatology 2018; (78(3)):540-559 doi:10.1016/j.jaad.2017.10.006.
PMID: 29331385
5
Mixed cranial neuropathies due to occult perineural invasion of basal cell carcinoma.
Ashraf DC, Kalin-Hajdu E, Levin MH, Kersten RC
American journal of ophthalmology case reports 2019; (13()):136-139 doi:10.1016/j.ajoc.2018.12.018.
PMID: 30705997
6
Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT, Wu A, Figueira E, et al.
Future oncology (London, England) 2015; (11(22)):3003-10 doi:10.2217/fon.15.190.
PMID: 26437207
7
Basal Cell Carcinoma With Perineural Invasion: A Systematic Review and Pooled Survival Analysis.
Abushukur Y, Ibrahim Y, Cascardo C, et al.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2022; (48(11)):1159-1165 doi:10.1097/DSS.0000000000003593.
PMID: 36095258
8
[Exclusive radiotherapy for a facial basal cell carcinoma with trigeminal ganglion involvement].
Longeac M, Lapeyre M, Delbet Dupas C, et al.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2016; (20(4)):308-11.
PMID: 27105681
9
Perineural spread of basosquamous carcinoma to the orbit, cavernous sinus, and infratemporal fossa.
Amram AL, Hertzing WJ, Smith SV, et al.
Orbit (Amsterdam, Netherlands) 2018; (37(2)):110-114 doi:10.1080/01676830.2017.1383462.
PMID: 29053047
10
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
Peris K, Fargnoli MC, Kaufmann R, et al.
European journal of cancer (Oxford, England : 1990) 2023; (192()):113254 doi:10.1016/j.ejca.2023.113254.
PMID: 37604067
11
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K, Fargnoli MC, Garbe C, et al.
European journal of cancer (Oxford, England : 1990) 2019; (118()):10-34 doi:10.1016/j.ejca.2019.06.003.
PMID: 31288208
12
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ, Garbe C, Dessinioti C, et al.
European journal of cancer (Oxford, England : 1990) 2020; (128()):60-82 doi:10.1016/j.ejca.2020.01.007.
PMID: 32113941
13
Photoprotection for Skin of Color.
Tsai J, Chien AL
American journal of clinical dermatology 2022; (23(2)):195-205 doi:10.1007/s40257-021-00670-z.
PMID: 35044638
14
A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer.
Navarro-Bielsa A, Gracia-Cazaña T, Almagro M, et al.
Photodermatology, photoimmunology & photomedicine 2023; (39(5)):457-465 doi:10.1111/phpp.12878.
PMID: 37130164
15
Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G, Nova J, Rodriguez-Hernandez AE, et al.
The Cochrane database of systematic reviews 2016; (7()):CD011161 doi:10.1002/14651858.CD011161.pub2.
PMID: 27455163
16
Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis.
An S, Kim K, Moon S, et al.
Cancers 2021; (13(23)) doi:10.3390/cancers13235940.
PMID: 34885049

This page is for informational purposes only and does not constitute medical advice. Your dermatologist should set your follow-up schedule and evaluate any new, changing, persistent, or concerning skin changes.

Guide Contents